CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing innovative vaccines for cancer treatment by utilizing a unique cell line derived from Plasmacytoid Dendritic Cells. The goal is to create universal dendritic cell lines that can activate specific T cells to target various cancers, enhancing immunotherapy effectiveness across a broader…
The development of efficient vaccines for the treatment of cancers is a major public health issue but remains a challenge.
The induction of cytotoxic specific T cell able to recognize and lyse malignant cells is the main goal of immunotherapeutic strategies based on dendritic cells.
The fellow has developed a unique cell line (GEN2.2) from the new Plasmacytoid Dendritic Cell (PDC) type.
He demonstrated its tremendous potential in allogeneic setting to induce the activation and proliferation of s…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
